Literature DB >> 28761303

Neutrophilic Dermatosis of the Palms in Association with Myelodysplastic Syndrome.

Min-Young Yang1, Jeong-Min Kim1, Gun-Wook Kim1, Margaret Song1, Hoon-Soo Kim1, Hyun-Chang Ko1, Moon-Bum Kim1,2, Byung-Soo Kim1,2.   

Abstract

Entities:  

Year:  2017        PMID: 28761303      PMCID: PMC5500720          DOI: 10.5021/ad.2017.29.4.495

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


× No keyword cloud information.
Dear Editor: Neutrophilic dermatosis of the hands (NDH), a recently described condition, is a variant of Sweet's syndrome confined to the hands. NDH is characterized by erythematous, edematous plaques with a violaceous border that occur mostly on the hands1. NDH is classified as neutrophilic dermatosis of the palms (NDP) and dorsal hands (NDDH). NDDH, but not NDP, is known to be strongly associated with malignant diseases. We report a case of NDP associated with myelodysplastic syndrome. A 67-year-old woman with myelodysplastic syndrome presented to our clinic with an erythematous swollen patch on the right palm, which had persisted for 2 weeks. An initial solitary erythematous papule had progressed to the swollen patch with time. The patient experienced spontaneous pain and tenderness. She was undergoing cyclic chemotherapy with azacitidine for the myelodysplastic syndrome. Physical examination showed an erythematous swollen patch on the ulnar side of the right palm (Fig. 1A). Fever, arthralgia, or generalised malaise was not observed at presentation. Incision and drainage were performed under the clinical impression of a bacterial abscess, but no purulent discharge was observed. Histopathological findings showed an intraepithelial abscess and necrotic debris infiltrated infiltrated by inflammatory cells mainly composed of polymorphonuclear neutrophils (Fig. 2A, B).
Fig. 1

Neutrophilicdermatosis of the palms (NDP). (A) Physical examination showed a erythematous swollen patch containing purulent content on the ulnar side of right palm. (B) Erythematous swollen patch on right palm was improved after use of systemic steroids. (C) The lesion recurred on the opposite left palm after 5 months of initial onset.

Fig. 2

Intraepithelial abscess and necrotic debris infiltrated by inflammatory cells mainly composed of polymorphonuclear neutrophils were observed in histopathologic finding. Initial visit (A, B). Recurred lesion after 5 months of initial onset (C, D).

The patient was diagnosed as NDP with myelodysplastic syndrome and treated with systemic steroids. The dosages used were dexamethasone 5 mg per day by intramuscular injection for 3 days, followed by per oral methylprednisolone 16 mg daily tapered to 4 mg over 2 months. The erythematous patch on the right palm improved over 2 months (Fig. 1B). A lesion occurred on the left palm 5 months after the initial onset (Fig. 1C). Biopsy of the newly formed erythematous patch showed evidence of NDP (Fig. 2C, D). The clinical course showed steroid-dependant pattern during the total follow-up period of 8 months. NDP usually clinically manifests as an erythematous patch and rarely shows features of histopathological vasculitis. In contrast, NDDH clinically manifests as pustules and bullae. In a previous study, 3 patients with NDDH had pathologic findings of pustular vasculitis2. Another study suggested that differences in vasculitic features such as swollen endothelial cells, dilated small blood vessels, and fragmented cell nuclei between patients with NDP and those with NDDH may be associated with differences in the pathogenesis of these conditions3. However, the detailed mechanisms are not yet clear. NDDH, but not NDP, is known to be strongly associated with malignant diseases such as lung cancer, laryngeal cancer, and myelodysplastic syndrome4. However, no case of malignancy-associated NDP has yet been reported. Cytokines may play a role in the relationship between hematologic diseases, such as myelodysplastic syndrome and acute myeloid leukemia, and Sweet's syndrome. Hematologic diseases cause increases in interleukin (IL)-1 levels, which affect granulocyte-colony stimulating factor (G-CSF) levels. G-CSF recruits main pathogenetic immune function cell of Sweet's syndrome, neutrophils, to the skin via IL-65. The patient described herein had involvement of both palms, which is concurrent with myelodysplastic syndrome. To our knowledge, this is the first case to show an association between NDP and myelodysplastic syndrome. Moreover, this case is unique in that the patient with NDP showed clinicopathological characteristics of NDDH, such as an erythematous swollen patch, pustular plaque (clinical finding), and vasculitic features (histopathological finding). As NDH has been reported rarely, further studies are still needed to determine the exact mechanism, clinical classification, and clinical prognosis or comorbidity of NDH.
  5 in total

Review 1.  Neutrophilic dermatosis of the palms.

Authors:  Kaoru Imaoka; Sakae Kaneko; Yuji Harada; Masataka Ota; Minao Furumura; Eishin Morita
Journal:  J Dermatol       Date:  2012-03-06       Impact factor: 4.005

Review 2.  Sweet's syndrome: a neutrophilic dermatosis classically associated with acute onset and fever.

Authors:  P R Cohen; R Kurzrock
Journal:  Clin Dermatol       Date:  2000 May-Jun       Impact factor: 3.541

3.  A case of neutrophilic dermatosis of the dorsal hands with concomitant involvement of the lips.

Authors:  Ji Won Byun; Won Kyu Hong; Hee Jin Song; Sung Hyub Han; Hyeon Sook Lee; Gwang Seong Choi; Jeong Hyun Shin
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

Review 4.  Neutrophilic dermatosis of the hands: presentation of eight cases and review of the literature.

Authors:  Jesús Del Pozo; Felipe Sacristán; Walter Martínez; Sabela Paradela; Beatriz Fernández-Jorge; Eduardo Fonseca
Journal:  J Dermatol       Date:  2007-04       Impact factor: 4.005

Review 5.  Neutrophilic dermatosis of the hands: four new cases and review of the literature.

Authors:  Roger H Weenig; Alison J Bruce; Marian T McEvoy; Lawrence E Gibson; Mark D P Davis
Journal:  Int J Dermatol       Date:  2004-02       Impact factor: 2.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.